BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel S, Wadhwa M. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19. Biomed Pharmacother 2021;140:111785. [PMID: 34126316 DOI: 10.1016/j.biopha.2021.111785] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
Number Citing Articles
1 Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F, Farnamian Y, Jalali L. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 2022;124:151908. [PMID: 35662001 DOI: 10.1016/j.acthis.2022.151908] [Reference Citation Analysis]
2 Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R, Ghasemnejad T. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022;19:92. [PMID: 35619180 DOI: 10.1186/s12985-022-01814-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Palacios Y, Chavez-galan L. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? Pharmaceuticals 2022;15:616. [DOI: 10.3390/ph15050616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
5 Wang HC, Ke TY, Ko YC, Lin JJ, Chang JS, Cheng YB. Anti-Inflammatory Azaphilones from the Edible Alga-Derived Fungus Penicillium sclerotiorum. Mar Drugs 2021;19:529. [PMID: 34677428 DOI: 10.3390/md19100529] [Reference Citation Analysis]